美股-制藥業(yè)-美國制藥業(yè):瑞信2018年醫(yī)療會議要點(diǎn)

美股-制藥業(yè)-美國制藥業(yè):瑞信2018年醫(yī)療會議要點(diǎn)

ID:27439127

大?。?1.54 KB

頁數(shù):24頁

時(shí)間:2018-12-03

美股-制藥業(yè)-美國制藥業(yè):瑞信2018年醫(yī)療會議要點(diǎn)_第1頁
美股-制藥業(yè)-美國制藥業(yè):瑞信2018年醫(yī)療會議要點(diǎn)_第2頁
美股-制藥業(yè)-美國制藥業(yè):瑞信2018年醫(yī)療會議要點(diǎn)_第3頁
美股-制藥業(yè)-美國制藥業(yè):瑞信2018年醫(yī)療會議要點(diǎn)_第4頁
美股-制藥業(yè)-美國制藥業(yè):瑞信2018年醫(yī)療會議要點(diǎn)_第5頁
資源描述:

《美股-制藥業(yè)-美國制藥業(yè):瑞信2018年醫(yī)療會議要點(diǎn)》由會員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫

1、18November2018Americas/UnitedStatesEquityResearchPharmaceuticals&BiotechnologyResearchAnalystsVamilDivan,MD2125385394vamil.divan@credit-suisse.comUyEar2123251729uy.ear@credit-suisse.comMichaelV.MorabitoPh.D.2123257298michael.morabito@credit-suisse.comInancCaner2123255051inanc.cane

2、r@credit-suisse.comUSPharmaceuticalsCOMMENTDetailsFromtheDesert–TakeawaysFromtheCreditSuisse2018HealthcareConference■WehostedtheCreditSuisseAnnualHealthcareConferencelastweekinScottsdale,AZ.Wepresentbelowourmaintakeawaysfromtheweekbasedonourconversationswithcompanymanagementteams

3、andinvestors.Moredetailednotesfromourmeetingsareincluded.■DrugPricingStillinFocus,ButDifferingViewsonPotentialImpact:Conversationswithourcompanies,aswellaswithJohnO'Brien(HHS)andEthanSiegal(WashingtonExchange),makeitclearthateffortsaroundreformingUSdrugpricingwillremainapriorityfo

4、rtheTrumpAdministration.MostexpecttheAdministrationtocontinuetoworkonimplementingvariousmeasuresthatwerelaidoutintheBlueprint,butsignificantdebateremainsaroundwhatlegislationwillbeabletogetthroughadividedCongress.Inthenear-termweunderstandPharmaisworkinghardtotryandhavetheirobliga

5、tiontofundthedonutholecoveragegapreduced.Startingin2019,Pharmawillberesponsibleforcovering70%ofthegap(from50%currently)butcompaniesarehopingtotrimtheirliabilitydowntothe~63%rangethroughprovisionsthatmaygetaddedontoappropriationbillsthatneedtogetpassedbyyearend.■SentimentonUSPharma

6、LargeCapsSoftensSlightly:WithseverallargecapUSpharmastocksexperiencingstrongmovesinrecentmonths,wesensedinvestorsentimentonthegroupsofteningsomewhatattheconference.Astheylookfornewideasfor2019,investorsappeartobelookingmoretowardsEUPharmaandlargecapbiotechinsearchofnamesthathaveno

7、tparticipatedinsomeoftherecentmoves.Thatsaid,thebullishoutlooktheLLYteamexpressedfortheirdiabetesbusinesswasnoteworthyfollowingseveralpositivedevelopmentsfortheminthatspace.BMYandAGNaretwolargecapstocksthathavenotperformedwellandwhereinvestorsweresearchingforcatalyststhatcanhelptu

8、rnaroundthestories.Ironically,BMY

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動畫的文件,查看預(yù)覽時(shí)可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負(fù)責(zé)整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時(shí)聯(lián)系客服。
3. 下載前請仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動等原因無法下載或下載錯誤,付費(fèi)完成后未能成功下載的用戶請聯(lián)系客服處理。